Optical coherence tomography and confocal scanning laser tomography for assessment of macular edema

American Journal of Ophthalmology

Volumn 138, Issue 3, 2004, Pages 354-361

  Degenring, Robert F ^a,b   Aschmoneit, Insa ^a   Kamppeter, Bernd ^a   Budde, Wido M ^a   Jonas, Jost B ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYLEPHRINE; TROPICAMIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; HUMAN; MALE; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETINA MACULA EDEMA; ROC CURVE; SCANNING LASER TOMOGRAPHY; THICKNESS; TOMOGRAPHY; VISUAL ACUITY;

EID: 4544363331     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2004.04.021     Document Type: Article

References (46)

1. Machemer R., Sugita G., Tano Y. Treatment of intraocular proliferations with intravitreal steroids. Trans Am Ophthalmol Soc. 77:1979;171-180
2. Machemer R. Five cases in which a depot steroid (hydrocortisone acetate and methylprednisolone acetate) was injected into the eye. Retina. 16:1996;166-167
3. Penfold P., Gyory J., Hunyor A., Billson F. Exudative macular degeneration and intravitreal triamcinolone. A pilot study. Aust N Z J Ophthalmol. 23:1995;293-298
4. Danis R.P., Ciulla T.A., Pratt L.M., Anliker W. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina. 20:2000;244-250
5. Jonas J.B., Kreissig I., Degenring R.F. Repeated intravitreal injections of triamcinolone acetonide as treatment of progressive exudative age-related macular degeneration. Graef Arch Clin Exp Ophthalmol. 240:2002;873-874
6. Ranson N.T., Danis R.P., Ciulla T.A., Pratt L. Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration. Br J Ophthalmol. 86:2002;527-529
7. Jonas J.B., Kreissig I., Hugger P., Sauder G., Panda-Jonas S., Degenring R. Intravitreal triamcinolone acetonide for exudative age-related macular degeneration. Br J Ophthalmol. 87:2003;462-468
8. Gillies M.C., Simpson J.M., Luo W., et al. A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration one-year results. Arch Ophthalmol. 121:2003;667-673
9. Spaide R.F., Sorenson J., Maranan L. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology. 110:2003;1517-1525
10. Jonas JB, Akkoyun I, Budde WM, et al. Intravitreal re-injection of triamcinolone for exudative age-related macular degeneration. Arch Ophthalmol. Forthcoming
11. D'Amico D.J., Goldberg M.F., Hudson H. Anecortave Acetate Clinical Study Group. Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD) interim (month 6) analysis of clinical safety and efficacy. Retina. 23:2003;14-23
12. Eyetech Study Group. Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration Phase II study results. Ophthalmology. 110:2003;979-986
13. Jonas J.B., Hayler J.K., Söfker A., Panda-Jonas S. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol. 131:2001;468-471
14. Jonas J.B., Söfker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol. 132:2001;425-427
15. Martidis A, Duker JS, Greenberg PB, AH, Puliafito CA, Reichel E, Baumal C. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 2002;109:920-927
16. Antcliff R.J., Spalton D.J., Stanford M.R., Graham E.M., Ffytche T.J., Marshall J. Intravitreal triamcinolone for uveitic cystoid macular edema an optical coherence tomography study. Ophthalmology. 108:2001;765-772
17. Young S., Larkin G., Branley M., Lightman S. Safety and efficacy of intravitreal triamcinolone for cystoid macular edema in uveitis. Clin Exp Ophthalmol. 29:2001;2-6
18. Martidis A., Duker J.S., Puliafito C.A. Intravitreal triamcinolone for refractory cystoid macular edema secondary to birdshot retinochoroidopathy. Arch Ophthalmol. 119:2001;1380-1383
19. Degenring R.F., Jonas J.B. Intravitreal injection of triamcinolone acetonide as treatment of chronic uveitis. Br J Ophthalmol. 87:2003;361
20. Greenberg P.B., Martidis A., Rogers A.H., Duker J.S., Reichel E. Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol. 86:2002;247-248
21. Jonas J.B., Kreissig I., Degenring R.F. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion. Graef Arch Clin Exp Ophthalmol. 240:2002;782-783
22. Degenring R.F., Kamppeter B., Kreissig I., Jonas J.B. Morphologic and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion. Acta Ophthalmol. 81:2003;399-401
23. Benhamou N., Massin P., Haouchine B., Audren F., Tadayoni R., Gaudric A. Intravitreal triamcinolone for refractory pseudophakic macular edema. Am J Ophthalmol. 135:2003;246-249
24. Conway M.D., Canakis C., Livir-Rallatos C., Peyman G.A. Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular edema. J Cataract Refract Surg. 29:2003;27-33
25. Jonas J.B., Kreissig I., Degenring R.F. Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema. Am J Ophthalmol. 136:2003;384-386
26. Alldredge C.D., Garretson B.R. Intravitreal triamcinolone for the treatment of idiopathic juxtafoveal telangiectasis. Retina. 23:2003;113-116
27. Shahidi M., Ogura Y., Blair N.P., Rusin M.M., Zeimer R. Retinal thickness analysis for quantitative assessment of diabetic macular edema. Arch Ophthalmol. 109:1991;1115-1119
28. Holz F.G., Jorzik J., Schütt F., Flach U., Unnebrink K. Agreement among ophthalmologists in evaluating fluorescein angiograms in patients with neovascular age-related macular degeneration for photodynamic therapy eligibility (FLAP study). Ophthalmology. 110:2003;400-405
29. Huang D., Swanson E.A., Lin C.P., et al. Optical coherence tomography. Science. 254:1991;1178-1181
30. Hee M.R., Izatt J.A., Swanson E.A., et al. Optical coherence tomography of the human retina. Arch Ophthalmol. 113:1995;325-332
31. Wilkins J.R., Puliafito C.A., Hee M.R., et al. Characterization of epiretinal membranes using optical coherence tomography. Ophthalmology. 103:1996;2142-2151
32. Schuman J.S., Hee M.R., Puliafito C.A., et al. Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography. Arch Ophthalmol. 113:1995;586-596
33. Schuman J.S., Pedut-Kloizman T., Hertzmark E., et al. Reproducibility of nerve fiber layer thickness measurements using optical coherence tomography. Ophthalmology. 103:1996;1889-1898
34. Mistlberger A., Liebmann J.M., Greenfield D.S., et al. Heidelberg retina tomography and optical coherence tomography in normal, ocular hypertensive, and glaucomatous eyes. Ophthalmology. 106:1999;2027-2032
35. Blumenthal E.Z., Williams J.M., Weinreb R.N., Girkin C.A., Berry C.C., Zangwill L.M. Reproducibility of nerve fiber layer thickness measurements by use of optical coherence tomography. Ophthalmology. 107:2000;2278-2282
36. Massin P., Duguid G., Erginay A., Haouchine B., Gaudric A. Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy. Am J Ophthalmol. 135:2003;169-177
37. Kruse F.E., Burk R.O.W., Völcker H.E., Zinser G., Harbarth U. Reproducibility of topographic measurements of the optic nerve head with laser tomographic scanning. Ophthalmology. 96:1989;1320-1324
38. Dreher A.W., Tso P.C., Weinreb R.N. Reproducibility of topographic measurements of the normal and glaucomatous optic nerve head with the laser tomographic scanner. Am J Ophthalmol. 111:1991;221-229
39. Garway-Heath D.F., Poinoosawmy D., Wollstein G., et al. Inter- and intraobserver variation in the analysis of optic disc images comparison of the Heidelberg retina tomograph and computer assisted planimetry. Br J Ophthalmol. 83:1999;664-669
40. Hudson C., Flanagan J.G., Turner G.S., McLeod D. Scanning laser tomography Z profile signal width as an objective index of macular retinal thickening. Br J Ophthalmol. 82:1998;121-130
41. Ang A., Tong L., Vernon S.A. Improvement of reproducibility of macular volume measurements using the Heidelberg retinal tomograph. Br J Ophthalmol. 84:2000;1194-1197
42. Tong L., Ang A., Vernon S.A., et al. Sensitivity and specificity of a new scoring system for diabetic macular oedema detection using a confocal laser imaging system. Br J Ophthalmol. 85:2001;34-39
43. Hudson C., Flanagan J.G., Turner G.S., Chen H.C., Young L.B., McLeod D. Correlation of a scanning laser derived oedema index and visual function following grid laser treatment for diabetic macular oedema. Br J Ophthalmol. 87:2003;455-461
44. Ramrattan R.S., Wolfs R.C.W., Panda-Jonas S., et al. Visual field loss in the elderly prevalence, causes and associations with daily life functioning. The Rotterdam Study. Arch Ophthalmol. 119:2001;1788-1794
45. Schmidt-Erfurth U., Miller J.W., Sickenberg M., et al. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration results of retreatments in a phase 1 and 2 study. Arch Ophthalmol. 117:1999;1177-1187
46. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol. 103:1985;1796-1806